Singapore markets open in 5 hours 10 minutes

Episurf Medical AB (publ) (0QUT.L)

LSE - LSE Delayed price. Currency in SEK
Add to watchlist
0.2110-0.0280 (-11.72%)
At close: 03:26PM BST

Episurf Medical AB (publ)

Karlavägen 60
Stockholm 114 49
46 86 12 00 20

Full-time employees26

Key executives

NameTitlePayExercisedYear born
Mr. Pal RyforsChief Executive Officer4.5MN/A1983
Ms. Veronica WallinChief Financial OfficerN/AN/A1986
Ms. Katarina Flodström Ph.D.Chief Operating OfficerN/AN/A1975
Mr. Fredrik ZetterbergMarketing DirectorN/AN/A1975
Ms. Ylva BondeHead of QA & RAN/AN/A1979
Mr. Patrick JamnikPresident of Episurf Medical IncN/AN/A1983
Amounts are as of 31 December 2023, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in SEK.


Episurf Medical AB (publ), a medical device company, designs and manufactures implants and surgical instruments in Germany, Sweden, rest of Europe, the United States, and internationally. It offers Episealer Knee for repairing focal cartilage and bone defects to reduce pain and increase mobility in the patient's knee joint; Episealer implant, which is designed to fit anatomy and size of the lesion; Episealer toolkit; and Episealer Patellofemoral System, a system to treat osteoarthritis limited to the patellofemoral part of the knee joint. The company also provides Episealer Talus, a solution for the treatment of bone and cartilage defects in the talus bone of the ankle joint; Epioscopy to identify and visualize femoral knee joint cartilage and bone lesions, and tibia, as well as defects on the cruciate ligaments and menisci; Epiguide, a surgical drill guide; and µiFidelity, a web platform for order management, communication, personalized design, and surgical pre-planning. In addition, it is developing Episealer MTP implant, an implant for the MTP joint of the big toe in the foot. Further, the company offers Talus Osteotomy Guide (TOG) that is designed to fit on the patient's distal tibia using CT and MRI images; MRI protocol to ensure correct damage assessment, 3D visualization, and device design; and Damage Marking Report (DMR) that enables 3D visualization of damage in the joint surface and underlaying bone defects, as well as other findings relevant when selecting the right treatment for the patient. The company was formerly known as Diamorph Medtech AB and changed its name to Episurf Medical AB (publ) in 2010. Episurf Medical AB (publ) was incorporated in 2008 and is headquartered in Stockholm, Sweden.

Corporate governance

Episurf Medical AB (publ)’s ISS governance QualityScore as of 1 July 2024 is 4. The pillar scores are Audit: 7; Board: 2; Shareholder rights: 4; Compensation: 8.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.